MCID: CHR048
MIFTS: 46

Chronic Rhinitis

Categories: Bone diseases, Respiratory diseases, Smell/Taste diseases

Aliases & Classifications for Chronic Rhinitis

MalaCards integrated aliases for Chronic Rhinitis:

Name: Chronic Rhinitis 12 54 15 71 32
Rhinitis - Chronic 12

Classifications:



External Ids:

Disease Ontology 12 DOID:8252
ICD9CM 34 472.0
NCIt 49 C34479
SNOMED-CT 67 86094006
ICD10 32 J31.0
UMLS 71 C0008711

Summaries for Chronic Rhinitis

Disease Ontology : 12 A rhinitis which is persistent and long-lasting. It may occur with diseases such as syphilis, tuberculosis, rhinoscleroma, rhinosporidiosis, leishmaniasis, blastomycosis, histoplasmosis, and leprosy, all of which are characterized by the formation of inflamed lesions (granulomas) and the destruction of soft tissue, cartilage, and bone. Chronic rhinitis causes nasal obstruction, pus-filled discharge from the nose, and frequent bleeding.

MalaCards based summary : Chronic Rhinitis, also known as rhinitis - chronic, is related to vasomotor rhinitis and atrophic rhinitis, and has symptoms including rhinorrhea, purulent rhinitis and catarrh. An important gene associated with Chronic Rhinitis is HRH1 (Histamine Receptor H1), and among its related pathways/superpathways are Allograft rejection and Hematopoietic Stem Cells and Lineage-specific Markers. The drugs Histamine and Azelastine have been mentioned in the context of this disorder. Affiliated tissues include testes, bone and skin, and related phenotypes are digestive/alimentary and hematopoietic system

Related Diseases for Chronic Rhinitis

Diseases in the Rhinitis family:

Chronic Rhinitis

Diseases related to Chronic Rhinitis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 177)
# Related Disease Score Top Affiliating Genes
1 vasomotor rhinitis 30.7 TAC1 RNASE3 IL5
2 atrophic rhinitis 30.4 RHNO1 KIDINS220
3 ige responsiveness, atopic 30.1 RNASE3 IL5 IL4 IL13
4 maxillary sinusitis 30.0 RNASE3 MPO KIDINS220
5 rhinitis 29.7 RNASE3 IL5 IL4 IL33 IL13 HRH1
6 hypereosinophilic syndrome 29.6 RNASE3 MPO IL5 IL4 IL13 EPX
7 allergic rhinitis 29.4 TAC1 RNASE3 MPO IL5 IL4 IL13
8 proteasome-associated autoinflammatory syndrome 1 29.3 RNASE3 MPO IL5 IL4 IL13
9 otitis media 29.1 RNASE3 MPO IL5 IL4 IL13
10 bronchitis 29.1 TAC1 RNASE3 MPO IL5 IL4 IL13
11 allergic asthma 29.0 RNASE3 IL5 IL4 IL13 EPX
12 urticaria 28.9 RNASE3 IL5 IL4 IL13 HRH1
13 lung disease 28.9 RNASE3 MPO IL5 IL4 IL13 EDN1
14 pollen allergy 28.8 RNASE3 MPO IL5 IL13 GHITM EPX
15 pulmonary disease, chronic obstructive 28.4 TAC1 SIGLEC5 RNASE3 MPO IL5 IL4
16 common cold 28.3 RNASE3 KIDINS220 IL5 IL4 IL33 IL13
17 conjunctivitis 27.7 RNASE3 MPO IL5 IL4 IL33 IL13
18 allergic hypersensitivity disease 27.5 TAC1 RNASE3 IL5 IL4 IL33 IL13
19 dermatitis, atopic 27.3 TAC1 RNASE3 IL5 IL4 IL33 IL13
20 asthma 27.0 TAC1 RNASE3 MPO IL5 IL4 IL33
21 pharyngitis 10.9
22 eosinophil peroxidase deficiency 10.4 MPO EPX
23 nasopharyngitis 10.4
24 inflammatory bowel disease 4 10.4 RNASE3 EPX
25 idiopathic edema 10.4 MPO EDN1
26 chronic maxillary sinusitis 10.4 RNASE3 MPO
27 loeffler endocarditis 10.4 RNASE3 IL5
28 multiple cranial nerve palsy 10.4 RHNO1 MPO
29 subacute bacterial endocarditis 10.3 SIGLEC5 MPO
30 mediastinitis 10.3 RHNO1 MPO
31 prurigo nodularis 10.3 TAC1 RNASE3
32 collagenous colitis 10.3 RNASE3 MPO EPX
33 cytokine deficiency 10.3 IL5 IL13
34 nut allergy 10.3 IL5 IL13
35 chronic frontal sinusitis 10.3 RHNO1 KIDINS220
36 adhesive otitis media 10.3 RNASE3 MPO
37 frontal sinusitis 10.3 RHNO1 KIDINS220
38 proctitis 10.3 RNASE3 MPO EPX
39 aztreonam allergy 10.3 IL5 IL13
40 transient refractive change 10.3 TAC1 EDN1
41 chronic ethmoiditis 10.3 RHNO1 KIDINS220
42 angioimmunoblastic lymphadenopathy with dysproteinemia 10.3 IL5 IL13
43 pemphigoid gestationis 10.3 RNASE3 IL5
44 disseminated eosinophilic collagen disease 10.3 RNASE3 IL5 EPX
45 respiratory syncytial virus infectious disease 10.3 IL5 IL13
46 cefaclor allergy 10.3 IL5 IL13
47 cefuroxime allergy 10.3 IL5 IL13
48 ceftriaxone allergy 10.2 IL5 IL13
49 maxillary sinus inverted papilloma 10.2 RHNO1 KIDINS220
50 churg-strauss syndrome 10.2 RNASE3 MPO IL5

Comorbidity relations with Chronic Rhinitis via Phenotypic Disease Network (PDN):


Anxiety Bronchitis
Esophagitis Heart Disease
Hypertension, Essential

Graphical network of the top 20 diseases related to Chronic Rhinitis:



Diseases related to Chronic Rhinitis

Symptoms & Phenotypes for Chronic Rhinitis

UMLS symptoms related to Chronic Rhinitis:


rhinorrhea, purulent rhinitis, catarrh

MGI Mouse Phenotypes related to Chronic Rhinitis:

45
# Description MGI Source Accession Score Top Affiliating Genes
1 digestive/alimentary MP:0005381 9.7 DNAH5 ECE1 EDN1 IL13 IL33 IL4
2 hematopoietic system MP:0005397 9.65 COPS7A DNAH5 ECE1 EPX HRH1 IL13
3 immune system MP:0005387 9.32 COPS7A DNAH5 ECE1 EPX HRH1 IL13

Drugs & Therapeutics for Chronic Rhinitis

Drugs for Chronic Rhinitis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 63)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Histamine Approved, Investigational Phase 4 51-45-6 774
2
Azelastine Approved Phase 4 58581-89-8 2267
3
mometasone furoate Approved, Investigational, Vet_approved Phase 4 83919-23-7
4 Histamine Antagonists Phase 4
5 Histamine H1 Antagonists, Non-Sedating Phase 4
6 Histamine H1 Antagonists Phase 4
7
Histamine Phosphate Phase 4 51-74-1 65513
8 Anti-Asthmatic Agents Phase 4
9 Anti-Inflammatory Agents Phase 4
10 Bronchodilator Agents Phase 4
11 Analgesics, Non-Narcotic Phase 4
12 Olopatadine Hydrochloride Phase 4
13 Anti-Allergic Agents Phase 4
14 Analgesics Phase 4
15 Anti-Inflammatory Agents, Non-Steroidal Phase 4
16 Antirheumatic Agents Phase 4
17 Dermatologic Agents Phase 4
18
Licorice Approved Phase 2, Phase 3
19 Hormones Phase 3
20 Hormone Antagonists Phase 3
21 glucocorticoids Phase 3
22 Anti-Bacterial Agents Phase 3
23
Beclomethasone Phase 3 4419-39-0 20469
24 Antibiotics, Antitubercular Phase 3
25 Pharmaceutical Solutions Phase 2, Phase 3
26
Chlorpheniramine Approved Phase 2 132-22-9, 113-92-8 2725
27
Guaifenesin Approved, Investigational, Vet_approved Phase 2 93-14-1 3516
28
Theophylline Approved Phase 2 58-55-9 2153
29 Respiratory System Agents Phase 2
30 Neurotransmitter Agents Phase 2
31 Anti-Obesity Agents Phase 2
32 Expectorants Phase 2
33 Chlorpheniramine, phenylpropanolamine drug combination Phase 2
34 Appetite Depressants Phase 2
35 Vasodilator Agents Phase 2
36 Ginkgo Phase 2
37 Phosphodiesterase Inhibitors Phase 2
38
Capsaicin Approved Phase 1 404-86-4 1548943
39
Lidocaine Approved, Vet_approved 137-58-6 3676
40
Benzyl alcohol Approved 100-51-6 244
41
Ethanol Approved 64-17-5 702
42
Nitric Oxide Approved 10102-43-9 145068
43
Levocabastine Approved, Investigational 79516-68-0 54385
44
Budesonide Approved 51333-22-3 63006 5281004
45
Pseudoephedrine Approved 90-82-4 7028
46
Ephedrine Approved 299-42-3 9294
47
Phenylephrine Approved 59-42-7 6041
48
Oxymetazoline Approved, Investigational 1491-59-4 4636
49
Pomegranate Experimental, Investigational
50 Anesthetics

Interventional clinical trials:

(show all 36)
# Name Status NCT ID Phase Drugs
1 The Efficacy and Safety of Hyeonggaeyeongyo-tang for Chronic Rhinitis According to Pattern Identification in Korean Medicine Completed NCT02477293 Phase 4 Hyeonggaeyeongyo-tang
2 Safety and Efficacy of Olopatadine 0.6% and Azelastine 137 Mcg in Vasomotor Rhinitis Completed NCT00979615 Phase 4 Olopatadine HCL (Patanase) Nasal Spray, 0.6%;Azelastine HCl (Astelin) Nasal Spray, 137 mcg
3 Study of Asthma and Nasal Steroids for the American Lung Association-Airways Clinical Research Centers Completed NCT01118312 Phase 4 Mometasone Furoate monohydrate
4 Elaboration of Patient-friendly Treatment Strategy With Capsaicin Nasal Spray in Patients With Idiopathic Rhinitis Completed NCT02288156 Phase 4 Capsaicin;placebo
5 Surgical Reduction of the Inferior Turbinate Using a Coblation® Device for Treatment of Nasal Obstruction: A Prospective, Multi-center Clinical Study Terminated NCT00737906 Phase 4
6 Phase III Randomized Open-label Clinical Trial Comparing Cleanoze® Irrigation Device With Powder Preparation Versus Conventional Irrigation Method for Chronic Rhinitis Completed NCT02763241 Phase 3 Cleanoze®;Saline (Syringe irrigation)
7 Multicentre, Randomized, Double-blind, Parallel Group, Placebo-Controlled Study on the Therapeutic Efficacy and Safety of Beclomethasone Dipropionate Suspension for Inhalation 800 µg Twice Daily vs. Placebo Added to Antibiotic Therapy in Patients With Acute Rhinosinusitis Completed NCT01691677 Phase 3 beclomethasone dipropionate 800 mcg/2 ml suspension for nebulization,one administration b.i.d. for 14 days;placebo 2 ml suspension for nebulization, one administration b.i.d. for 14 days
8 Impact of Acupuncture on Vasomotor Rhinitis: a Randomised Placebo Controlled Pilot Study Completed NCT00682162 Phase 3
9 Chia Yi Chang Gung Memorial Hospital Recruiting NCT04046393 Phase 2, Phase 3
10 The Effect of Oral Guaifenesin on Pediatric Chronic Rhinitis: A Pilot Study Completed NCT01364467 Phase 2 Placebo;Guaifenesin
11 Effects of Oral Ginkgo Biloba Extract on Pregnancy Complicated by Asymmetrically Intrauterine Growth Restriction: a Double-blinded Randomized Placebo-controlled Trial Completed NCT02425436 Phase 2 Ginkgo Biloba Extract
12 The Effect of Theophylline in Patients With Allergic Rhinitis Completed NCT01132781 Phase 2 Theophylline (Intervention Group);Placebo (Placebo Group)
13 Tolerability of Intranasal Capsaicinoid Spray Recruiting NCT03952845 Phase 1
14 The Clinical Efficacy of Topical Nasal Pomegranate Fruit Extract (PFE) for Patients With Chronic Rhinitis, Chronic Sinusitis With or Without Nasal Polyps Unknown status NCT01564849
15 The Correlation Between Adenoid Hypertrophy and Body Temperature in Children Before and After Adenoidectomy Unknown status NCT02965183
16 Nasal Findings in Reactive Airway Diseases Unknown status NCT03131323
17 A Randomized Double Dummy Double Blind Dose Determining Place-bo Controlled Study to Evaluate Efficacy of Investigational Product E-RH-06 at 2 Dose Levels for the Metabolic Management of Chronic or Recurrent, Non-infective Nasal Congestion With-or-without Rhinorrhea. Unknown status NCT01546662
18 Real-life Management and Therapeutic Outcome of Patients With Chronic Rhinitis and Chronic Urticaria in Thailand Completed NCT02000648
19 Feasibility Study of Multi-Treatment Posterior Nasal Nerve Modulation for Treatment of Chronic Rhinitis Completed NCT03791489
20 Clinical Evaluation of Cryotherapy in the Nasal Passageway Using the ClariFix Device Completed NCT02820597
21 XprESS Device and PathAssist Confirmation Tools in Pediatric Patients-Expanded Indication Study Completed NCT02278484
22 A Randomized Comparison Study of Temperature-controlled and Bipolar Radiofrequency for Inferior Turbinate Reduction in Patients With Chronic Rhinitis Completed NCT01054521
23 Are Technicians Showing Bronchial Hyperreactivity Able to Safely Perform Bronchial Provocation Tests? Completed NCT01937494 histamine-benzylic alcohol (magistral preparation)
24 Evaluation Effects of Nasal Nitric Oxide Measurements Are Associated With Atopy Status in Chronic Nasal Inflammation Completed NCT01295866
25 Periostin Levels in Children With Adenoid Hypertrophy Completed NCT04152746
26 Seinäjoki Adult Asthma Study: A 12-year Real-life Follow-up Study of New-onset Asthma Diagnosed at Adult Age and Treated in Primary and Specialized Care. Finnish Title: Diagnoosista Hoitotasapainoon: Voidaanko Aikuisen Astman Hoitotasapainoa Ennustaa Diagnoosivaiheen löydösten ja Astman Ilmiasun Perusteella? Completed NCT02733016
27 Impact of Age on the Prevalence of Allergic Sensitization Completed NCT02730520
28 Phenotyping the Chronic Respiratory Diseases (CRD) in Ho Chi Minh City, Vietnam Completed NCT02517983
29 ClariFix Rhinitis Randomized Controlled Trial Recruiting NCT04154605
30 Study of Medication for Nonallergic Rhinitis (NAR) Based on Cluster Analysis Recruiting NCT04002349 Budesonide Nasal Spray (Rhinocort, Shanghai Johnson & Johnson Pharmaceuticals, Ltd.);Levocabastine Nasal Spray (Livostine, Shanghai Johnson & Johnson Pharmaceuticals, Ltd.);0.9% natural saline
31 Identification of Mediators Associated With Presence of Nasal Hyperreactivity in Allergic Rhinitis and Chronic Rhinosinusitis Recruiting NCT04286542
32 Clinical Evaluation of Safety and Efficacy for the ClariFix™ Cryotherapy Device in Subjects With Chronic Rhinitis Active, not recruiting NCT03181594
33 Clinical Evaluation of Low Power Radiofrequency Energy Applied to the Posterior Nasal Nerve Area for Symptomatic Relief of Chronic Rhinitis Active, not recruiting NCT03727347
34 A Prospective, Multi-Center Registry of Subjects Treated With the ClariFix Cryotherapy Device Active, not recruiting NCT03739216
35 Oxymetazoline Hydrochloride in Combination With Nasal Glucocorticosteroid for Perennial Allergic and Non-allergic Rhinitis in Subjects With Persistent Nasal Congestion Terminated NCT00584662 Oxymetazoline Hydrochloride
36 Olfactory Training for Olfactory Dysfunction in Chronic Rhinosinusitis Withdrawn NCT03055572

Search NIH Clinical Center for Chronic Rhinitis

Genetic Tests for Chronic Rhinitis

Anatomical Context for Chronic Rhinitis

MalaCards organs/tissues related to Chronic Rhinitis:

40
Testes, Bone, Skin, Lung, T Cells, Neutrophil, Thyroid

Publications for Chronic Rhinitis

Articles related to Chronic Rhinitis:

(show top 50) (show all 869)
# Title Authors PMID Year
1
Further improvement of quality of life by cetirizine in perennial allergic rhinitis as a function of treatment duration. 61 54
10879992 2000
2
Allergic rhinitis in children: effects of flunisolide and disodium cromoglycate on nasal eosinophil cationic protein. 61 54
9088653 1997
3
Evaluation of Acupuncture's Efficacy Within Otolaryngology. 61
32090591 2020
4
Diagnosis and management of nonallergic rhinitis with eosinophilia syndrome using cystatin SN together with symptoms. 61
32577150 2020
5
Environmental factors in epithelial barrier dysfunction. 61
32507229 2020
6
Immunoactive preparations and regulatory responses in the respiratory tract: potential for clinical application in chronic inflammatory airway diseases. 61
32250709 2020
7
Prevalence of Eustachian Tube Dysfunction in the US Elderly Population. 61
32573346 2020
8
Epithelial barriers in allergy and asthma. 61
32507228 2020
9
Outside-in hypothesis revisited: the role of microbial, epithelial and immune interactions. 61
32454094 2020
10
Local Allergic Rhinitis Revisited. 61
32430616 2020
11
Predictors of rhinorrhea response after posterior nasal nerve cryoablation for chronic rhinitis. 61
32445248 2020
12
Laser ablation of posterior nasal nerves for rhinitis. 61
31948695 2020
13
Current and Future Treatments of Rhinitis and Sinusitis. 61
32004747 2020
14
Metal particles in mucus and hypertrophic tissue of the inferior nasal turbinates from the human upper respiratory tract. 61
32410192 2020
15
Relation between volume of sphenoid sinuses and protrusion of Vidian nerve: possible applications to Vidian neurectomy. 61
31897657 2020
16
Chronic non-allergic rhinitis with neutrophils is associated with higher acid exposure time: A pH-impedance monitoring study. 61
31874835 2020
17
CTNNB1 (β-CATENIN) VITREORETINOPATHY: IMAGING CHARACTERISTICS AND SURGICAL MANAGEMENT. 61
32150115 2020
18
Effect of Montelukast on the Symptom Severity Score of Allergic Rhinitis. 61
32337129 2020
19
Chronic Rhinitis in the Cat: An Update. 61
31879130 2020
20
Treating acute rhinitis and exacerbations of chronic rhinitis - A role for topical decongestants? 61
32242436 2020
21
Activation of the Nrf2/HO-1 pathway by curcumin inhibits oxidative stress in human nasal fibroblasts exposed to urban particulate matter. 61
32228565 2020
22
Pattern of allergic sensitization in chronic rhinitis: A 19-year retrospective study. 61
32247303 2020
23
Longitudinal Relationships between Asthma-Specific Quality of Life and Asthma Control in Children; The Influence of Chronic Rhinitis. 61
32085584 2020
24
Should Excess Topical Decongestant Use Raise a Red Flag? Rhinitis Medicamentosa and Opioid Use Disorder. 61
31581795 2020
25
Spontaneous Cerebrospinal Fluid Leak Presenting as Chronic Rhinitis. 61
31606393 2020
26
Multidisciplinary Real-World Experience With Bilastine, a Second Generation Antihistamine 61
32129958 2020
27
Prognostic Value of Clinical Biochemistry-Based Indexes in Nasopharyngeal Carcinoma. 61
32211311 2020
28
Airway Epithelial Dynamics in Allergy and Related Chronic Inflammatory Airway Diseases. 61
32292784 2020
29
The Clinical Significance of Nasal Nitric Oxide Concentrations in Preschool Children with Nasal Inflammatory Disease. 61
31752005 2020
30
The Microbiome of the Nose-Friend or Foe? 61
32206384 2020
31
The impact of comorbidities on severe asthma. 61
31644439 2020
32
Clinical features and associated factors with severe asthma in Salvador, Brazil. 61
32187258 2020
33
Characterization of nasal irrigation flow from a squeeze bottle using computational fluid dynamics. 61
31691535 2020
34
Does the Hospital Admission of Patients with Respiratory Disease Increase in Izmir When the PM10 Level is High? 61
32163361 2020
35
Effect of fluticasone propionate on human nasal fibroblasts exposed to urban particulate matter. 61
31822346 2019
36
The impact of bilateral endoscopic inferior turbinoplasty with or without adenoidectomy on the quality of life of children: a retrospective case series study. 61
31791402 2019
37
[Discussion on safety of Xanthii Fructus and consideration on its rational use]. 61
32237377 2019
38
Allergic and Mixed Rhinitis: Diagnosis and Natural Evolution. 61
31752308 2019
39
Mometasone furoate is not superior to saline for chronic rhinitis in the elderly. 61
31641400 2019
40
Cryosurgical ablation for treatment of rhinitis: A prospective multicenter study. 61
31566744 2019
41
Specific immunoglobulin E in nasal secretions for the diagnosis of local allergic rhinitis. 61
31129685 2019
42
Life-long endogenous estrogen exposure is associated with prevalence of allergic rhinitis in postmenopausal women. 61
30889092 2019
43
[Endoscopic posterior nasal neurectomy]. 61
31439065 2019
44
[The role and research progress of exosomes in chronic inflammatory diseases of airway]. 61
31327215 2019
45
How to Diagnose and Treat Local Allergic Rhinitis: A Challenge for Clinicians. 61
31331047 2019
46
Group 2 Innate Lymphoid Cells in Airway Diseases. 61
31082387 2019
47
[The significance of eosinophils in the correlation of upper and lower airway inflammation in patients with chronic rhinitis]. 61
31262111 2019
48
The prevalence and characteristics of local allergic rhinitis in Poland. 61
30556065 2019
49
The role of nasal cytology in the diagnosis of allergic and non-allergic rhinitis in adult and children. 61
31298361 2019
50
Mucoid Pseudomonas aeruginosa infection in a cat with severe chronic rhinosinusitis. 61
31210366 2019

Variations for Chronic Rhinitis

Expression for Chronic Rhinitis

Search GEO for disease gene expression data for Chronic Rhinitis.

Pathways for Chronic Rhinitis

GO Terms for Chronic Rhinitis

Cellular components related to Chronic Rhinitis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 extracellular space GO:0005615 9.61 TAC1 RNASE3 MPO IL5 IL4 IL33
2 extracellular region GO:0005576 9.32 TAC1 RNASE3 MPO IL5 IL4 IL33
3 Weibel-Palade body GO:0033093 9.16 EDN1 ECE1

Biological processes related to Chronic Rhinitis according to GeneCards Suite gene sharing:

(show all 14)
# Name GO ID Score Top Affiliating Genes
1 regulation of vasoconstriction GO:0019229 9.54 EDN1 ECE1
2 positive regulation of interleukin-4 production GO:0032753 9.52 IL33 EPX
3 positive regulation of macrophage activation GO:0043032 9.51 IL33 IL13
4 positive regulation of renal sodium excretion GO:0035815 9.49 TAC1 EDN1
5 macrophage activation GO:0042116 9.48 IL4 IL13
6 positive regulation of immunoglobulin secretion GO:0051024 9.46 IL5 IL33
7 response to lipopolysaccharide GO:0032496 9.46 TAC1 MPO IL13 EDN1
8 inositol phosphate-mediated signaling GO:0048016 9.43 HRH1 EDN1
9 positive regulation of interleukin-10 secretion GO:2001181 9.4 IL4 IL13
10 positive regulation of mast cell degranulation GO:0043306 9.37 IL4 IL13
11 positive regulation of interleukin-13 production GO:0032736 9.32 IL4 IL33
12 regulation of systemic arterial blood pressure by endothelin GO:0003100 9.26 EDN1 ECE1
13 positive regulation of B cell proliferation GO:0030890 9.13 IL5 IL4 IL13
14 negative regulation of complement-dependent cytotoxicity GO:1903660 8.62 IL4 IL13

Molecular functions related to Chronic Rhinitis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 cytokine activity GO:0005125 9.02 IL5 IL4 IL33 IL13 EDN1

Sources for Chronic Rhinitis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
53 NINDS
54 Novoseek
56 OMIM
57 OMIM via Orphanet
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
Content
Loading form....